Women in England with incurable breast cancer to get life-extending drug on NHS
Thousands of women in England with incurable HER2-low advanced breast cancer will gain access to the life-extending drug Enhertu on the NHS following a successful price negotiation. The National Institute for Health and Care Excellence (Nice) reversed its previous rejection of the treatment, citing a new commercial agreement that allows for higher annual spending limits. Clinical trials indicate that Enhertu significantly improves median progression-free and overall survival compared to standard chemotherapy.
- ▪Approximately 1,000 women per year in England will be eligible to receive Enhertu from the NHS starting in September 2026.
- ▪Nice previously rejected the drug in July 2024 due to cost concerns but changed its stance after brokers negotiated a commercial solution.
- ▪Enhertu has been available in Scotland since December 2023 and is currently provided in 27 European countries.
- ▪Clinical data shows the drug increased median progression-free survival from 5.1 to 9.9 months and median overall survival from 16.8 to 23.4 months.
- ▪Ministers in Wales and Northern Ireland are expected to implement the same recommendation to make the drug available in their regions.
2 outlets in our directory ran this story, first to last over 3 hours. All of the coverage we found sits in one bucket: centre. That one-sidedness is itself worth noticing.
The Guardian — World publishes from United Kingdom and files mainly under world. We currently carry 3,588 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Guardian — World |
| Canonical URL | https://www.theguardian.com/society/2026/sep/17/women-england-incurable-breast-cancer-life-extending-drug-enhertu-nhs |
| Publication time | Thu, 17 Sep 2026 05:00:40 GMT |
| Retrieval time | 2026-09-17T05:13:42.146Z |
| Last seen | 2026-09-17T05:13:42.146Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | ybc1eAtaYIpA · 2 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
The drug has been available since 2023 in Scotland, one of 27 European countries that provide it. Photograph: Astra Zeneca/ReutersView image in fullscreenThe drug has been available since 2023 in Scotland, one of 27 European countries that provide it. Photograph: Astra Zeneca/ReutersBreast cancerWomen in England with incurable breast cancer to get life-extending drug on NHSThousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on priceDenis Campbell and Anna BawdenThu 17 Sep 2026 01.00 EDTLast modified on Thu 17 Sep 2026 01.02 EDTSharePrefer the Guardian on GoogleThousands of women in England with incurable breast cancer will get access to a life-extending drug on the NHS after negotiations over its cost proved successful.About 1,000 women a…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Guardian — World.
Discussion
0 commentsMore from The Guardian — World
